Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone for Corticosteroid-Induced Memory Impairment
NCT01828515Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vilazodone in Memory impairment, sponsored by UT Southwestern Medical Center. Started Dec 2012; status: completed.
02
Drugs
vilazodone
03
Conditions
Memory impairment
Beyond the preview
Go deeper on NCT01828515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828515.